Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Fibroblast growth factor signaling requires Xmig6 for muscle differentiation in Xenopus embryos. Fibroblast growth factor signaling may involve XGPCR4 (show GPR84 Antibodies) in gastrulation.
ectopic expression of Gene 33 triggers DNA damage response in an ATM serine/threonine kinase (ATM)-dependent fashion and through pathways dependent or not dependent on ABL proto-oncogene 1 non-receptor tyrosine kinase (c-Abl).
our data suggest that dormant cancer cells with a high MIG6 expression level might be one of the causes of EGFR (show EGFR Antibodies)-TKI resistance in EGFR (show EGFR Antibodies) mutant lung cancer cells.
Down-regulation of Mig-6 induces Cyclin D1 (show CCND1 Antibodies) expression and activates the MAPK-ERK (show MAPK1 Antibodies) signaling pathway. Our study shows that the expression of Mig-6 protein is low in hepatocellular carcinoma, which predicts a poor prognosis.
PIPKIgammai5, NEDD4-1 (show NEDD4 Antibodies), and Mig6 form a novel molecular nexus that controls EGFR (show EGFR Antibodies) activation and downstream signaling.
Low MIG6 expression is associated with lung cancer.
MIG6 down regulation may promote the migration and invasiveness of MEK (show MAP2K1 Antibodies) inhibited mutant NRAS (show NRAS Antibodies) melanoma.
MIG6 is a potent tumor suppressor for mutant EGFR (show EGFR Antibodies)-driven lung tumor initiation and progression in mice and provides a possible mechanism by which mutant EGFR (show EGFR Antibodies) can partially circumvent this tumor suppressor in human lung adenocarcinoma.
Crystal structures of human EGFR (show EGFR Antibodies)-Mig6 complexes show how Mig6 rearranges after phosphorylation by EGFR (show EGFR Antibodies) to effectively irreversibly inhibit the same receptor that catalyzed its phosphorylation.
MIG-6 efficiently reduces cellular transformation driven by oncogenic BRAF (show BRAF Antibodies) by orchestrating a negative feedback circuit directed towards the EGFR (show EGFR Antibodies).
study provides a new molecular mechanism to regulate EGFR (show EGFR Antibodies) signaling through modulation of MIG6 by DNAJB1 (show DNAJB1 Antibodies) as a negative regulator.
Studies indicate that progesterone receptor (show PGR Antibodies) transgenic (Pgrcre/+) mitogen inducible gene 6 (Mig (show CXCL9 Antibodies)-6over) phosphatase and tensin homolog (show PTEN Antibodies) protein (Ptenf/f) knockout mice exhibited an increase of phospho-ERK1/2 (show MAPK1/3 Antibodies) and its target genes.
mouse Mig-6 ablation in the liver results in multiple metabolic phenotypes such as fatty liver, fasting hyperglycemia, and hypercholesterolemia but in lower bodyweight and improved insulin (show INS Antibodies) sensitivity.
Liver-specific ablation of Mig-6 caused hyperglycemia by hepatic insulin (show INS Antibodies) resistance.
This microarray analysis also revealed that 324 genes are regulated by P4 as well as Mig-6. Cited2 (show CITED2 Antibodies), the developmentally important transcription factor, was identified as being regulated by the P4-Mig-6 axis
Mig-6 plays a critical role in the development of atherosclerosis.
our findings suggest that Mig-6 regulates ERK1/2 (show MAPK1/3 Antibodies) phosphorylation and that it is crucial for progression of PTEN (show PTEN Antibodies)-mutant endometrial cancers, providing a mechanistic rationale for the evaluation of ERK1/2 (show MAPK1/3 Antibodies) inhibitors
MIG-6 expression in chondrocytes is important for the maintenance of cartilage and joint homeostasis.
Cartilage-specific deletion of Mig-6 results in osteoarthritis-like disorder with excessive articular chondrocyte proliferation.
This treatment had no effect in PR(cre/+)Mig-6(f/f) mice where Mig-6 was deleted in both the epithelial and stromal compartments of the uterus.
Cytoplasmic ribosomes, organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein, which shares sequence similarity with yeast ribosomal protein L44, belongs to the L44E (L36AE) family of ribosomal proteins. Although this gene has been referred to as ribosomal protein L44 (RPL44), its official name is ribosomal protein L36a (RPL36A). This gene and the human gene officially named ribosomal protein L36a-like (RPL36AL) encode nearly identical proteins\; however, they are distinct genes. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. Naturally occurring read-through transcription occurs between this locus and the heterogeneous nuclear ribonucleoprotein H2 (H') gene.
ERBB receptor feedback inhibitor 1
, mitogen-inducible gene 6 protein
, mitogen-inducible gene 6-like protein
, ERBB receptor feedback inhibitor 1-like
, receptor-associated late transducer
, mitogen-inducible gene 6 protein homolog
, gene 33 polypeptide
, 60S ribosomal protein L36a
, 60S ribosomal protein L44
, L44-like ribosomal protein
, cell growth-inhibiting gene 15 protein
, cell migration-inducing gene 6 protein
, dJ164F3.3 (ribosomal protein L44)